Description

BPC-157 / TB500 Blend

The BPC-157 (5 mg) + TB500 (5 mg) Blend is designed to support studies of how two peptide reagents interact within experimental tissue-response systems. BPC-157 has been investigated for growth-factor-associated and inflammatory signaling, while thymosin β4-related molecules have been studied for actin-associated cellular processes. Combined effects have not been established and depend on the exact TB500 material supplied.

RESEARCH

The BPC-157/TB500 Blend is provided exclusively for in vitro research. It can be used to investigate molecular interactions, cellular movement, and tissue-remodeling responses in controlled laboratory conditions. TB500 is used inconsistently for distinct thymosin β4-related compounds; confirm the actual peptide identity on the supplier COA before listing sequence or molecular properties. No therapeutic claims are made.

CHEMICAL INFORMATION

BPC-157:

• Molecular Weight: 1419.55 Da
• CAS Number: 137525-51-0

TB-500:

• Molecular Weight: 889.01 Da
• CAS Number: 885340-08-9

RESEARCH APPLICATIONS

• Cell Migration: Investigate peptide-associated changes in motility in defined cell models.
• Tissue Remodeling: Examine extracellular-matrix and repair-related signaling responses.
• Actin-Related Pathways: Explore actin dynamics where supported by the verified TB500 identity.
• Inflammatory Signaling: Study experimental mediator and stress-response pathways.

STORAGE AND HANDLING

• Store lyophilized powder at -20°C, subject to product-specific stability data.
• After reconstitution, follow a validated laboratory stability protocol and use promptly.
• Protect from direct sunlight and avoid repeated freeze-thaw cycles.
• Maintain aseptic techniques during laboratory handling to minimize contamination.

PRODUCT SPECIFICATION

• Purity:  ≥99% (HPLC)
• Appearance: Lyophilized powder
• Solubility: Soluble in sterile water or appropriate aqueous laboratory buffers

COMPLIANCE NOTICE

BPC-157 (5 mg) + TB500 (5 mg) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This research product is not to be used for therapeutic, diagnostic, or clinical purposes. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

BENEFITS BEING RESEARCHED

• Experimental tissue-remodeling responses
• Cell motility and migration pathways
• Growth-factor-associated molecular signaling
• Actin-associated dynamics in relevant laboratory systems
• Inflammatory response markers in preclinical models
• Potential peptide interactions requiring direct experimental validation

MECHANISM OF ACTION (Simplified)

• BPC-157: Research explores growth-factor-associated signaling, cellular migration, and inflammation-linked responses.
• TB500: Its mechanism depends on whether the supplied material is full-length thymosin β4 or a particular fragment; verify the COA.
• Blend Research: Investigate whether the two verified components produce additive, neutral, or other responses in vitro.
• Overall research focus = cell migration and repair-associated pathways; synergistic effects are not established.

FORM / NOTES

Lyophilized vial containing BPC-157 5 mg and TB500 5 mg (10 mg total).
Before publishing chemical identity claims, verify the TB500 sequence and chemical form against the supplier COA.

LEGAL DISCLAIMER

This product is sold strictly for laboratory research use only.

By purchasing this product, the buyer represents and warrants that:

• The material will be used solely for in-vitro research purposes
• The buyer is qualified to handle laboratory reagents
• The product will not be used for human or animal consumption, injection, or application

Revyon Technologies assumes no liability for misuse or improper handling.

IMPORTANT NOTICE

Any use outside of stated research purposes is strictly prohibited.